Skip to main content

Sunny Malhotra Sareen

I am a biomedical researcher who serves as the Principal Investigator at the Clinical Neuroimmunology Unit of the Vall d'Hebron Research Institute.

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Sunny Malhotra Sareen

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

I am a biomedical researcher who serves as the Principal Investigator at the Clinical Neuroimmunology Unit of the Vall d'Hebron Research Institute.

As the Principal Investigator, I have a strong commitment to Translational Research and a solid background in biomedical sciences. My expertise lies in the discovery of biomarkers through genetic indicators and gene expression, particularly in identifying new therapeutic targets for neurological diseases. Additionally, I have over a decade of involvement in pharmacogenetics, genomics, and inflammasome biology studies.

I have received training from various institutions, including the National Institute of Immunology (New Delhi), the Institute of Genomics and Integrative Biology (New Delhi), Progenika Biopharma, and UKE Hamburg.

Dr. Malhotra has developed research lines funded by the Carlos III Health Institute during the periods 2017-2019 and 2021-2024.

Selected awards/grants granted to the PI include:

"Novartis Award" for the best oral communication;
"Extraordinary Award" of the year for his "Doctorate" (UPF);
"Merck Solidarity Award" for multiple sclerosis of the year;
"Hope Award" for multiple sclerosis of the year;
"Marie Curie Fellowship": as a predoctoral researcher;
"Educational Fellowship": from ECTRIMS (Boston);
"PERIS Fellowship": as a postdoctoral researcher.
I serve as a lecturer and have extensive experience reviewing research articles in international journals. I am a member of various scientific editorial committees and have supervised master's and doctoral theses with 'Cum Laude' honors.

I am a member of the Human Resources Strategy for Researchers (HRS4R) Committee at the center, with the main motto of promoting excellence in science in Europe.

In general, my primary research focus includes neuroinflammatory/neurodegenerative diseases and the search for new biomarkers/therapeutic target objectives and drug discovery.

Projects

Red Española de Esclerosis Múltiple

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Silvia Soler García, Carmen Tur Gomez, Cristina Auger Acosta, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 198090
Reference: RD12/0032/0017
Duration: 01/01/2013 - 31/12/2016

Búsqueda de biomarcadores en esclerosis múltiple (EM) basada en perfiles de expresión génica mediante ultrasecuenciación

IP: Xavier Montalban Gairín
Collaborators: Sunny Malhotra Sareen
Funding agency: Instituto de Salud Carlos III
Funding: 185130
Reference: PI10/02099
Duration: 01/01/2011 - 31/03/2015

Búsqueda de marcadores de bioactividad del interferón-beta alternativos a la proteína MXA

IP: Manuel Comabella Lopez
Collaborators: Sunny Malhotra Sareen, Xavier Montalban Gairín
Funding agency: Fundación Merck Salud
Funding: 20000
Reference: MERCK-2009-05
Duration: 01/04/2010 - 31/03/2011

Unitat de Neuroimmunologia Clínica (UNiC)

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 793
Duration: 01/01/2010 - 30/04/2014

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Elisabet Miro Casas

Elisabet Miro Casas

Research technician
Cardiovascular Diseases
Read more
Edurne Ruiz Marti

Edurne Ruiz Marti

Infectious Diseases
Read more
Ariadna Campos Martorell

Ariadna Campos Martorell

Growth and Development
Read more
Marta Aguayo Álvarez

Marta Aguayo Álvarez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.